Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16

Table 1

Summary of treatments performed in mice.

Groups	Treatments	Route of administration
I	Nothing	—
II	PBS
III	pVAX
IV	pVAX-GRA1

mouse, 100 μg pVAX I resuspended in 100 μl PBS. mouse, 100 μg pVAX-GRA16 dissolved in 100 μl PBS. mouse, individually injecting the leg muscle 3 times, at a 2-week interval.